Detalles de la búsqueda
1.
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.
Am J Transplant
; 22(4): 1133-1144, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910841
2.
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.
Clin Transplant
; 36(8): e14734, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657013
3.
Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimus.
Transpl Infect Dis
; 24(2): e13805, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35213773
4.
Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
Pediatr Transplant
; 26(8): e14400, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36168673
5.
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection.
Am J Transplant
; 20 Suppl 4: 42-56, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32538536
6.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
N Engl J Med
; 377(5): 442-453, 2017 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28767349
7.
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
Am J Transplant
; 18(12): 2955-2964, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29637714
8.
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Kidney Int
; 91(3): 729-737, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28104301
9.
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients.
Pediatr Transplant
; 21(8)2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28929636
10.
Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Transpl Int
; 29(12): 1276-1285, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27529314
11.
Risk factors associated with the development of histocompatibility leukocyte antigen sensitization.
Curr Opin Organ Transplant
; 21(4): 447-52, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27258577
12.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
N Engl J Med
; 377(17): 1693-4, 2017 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29083132
13.
Kidney transplantation in highly sensitized patients.
Br Med Bull
; 114(1): 113-25, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935575
14.
Early recognition of risk factors for adverse outcomes during hospitalization among Medicare patients: a prospective cohort study.
BMC Geriatr
; 13: 72, 2013 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23834816
15.
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.
Kidney Int Rep
; 7(4): 720-731, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35497778
16.
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro.
Transplantation
; 104(8): 1574-1579, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732834
17.
Interleukin-6: An Important Mediator of Allograft Injury.
Transplantation
; 104(12): 2497-2506, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32235253
18.
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients.
Transplantation
; 104(7): 1500-1507, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31568398
19.
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
Clin J Am Soc Nephrol
; 15(1): 109-116, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843975
20.
Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
Transplantation
; 103(12): 2666-2674, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883456